Provided by Tiger Trade Technology Pte. Ltd.

NUTRIBAND INC C/WTS (TO PUR COM)

1.35
0.0000
Volume:901.00
Turnover:1.46K
Market Cap:18.82M
PE:-0.44
High:1.35
Open:1.35
Low:1.35
Close:1.35
52wk High:4.50
52wk Low:0.8000
Shares:13.94M
Float Shares:13.94M
Volume Ratio:4.40
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0655
ROE:-136.08%
ROA:-55.22%
PB:2.49
PE(LYR):- -

Loading ...

Company Profile

Company Name:
NUTRIBAND INC C/WTS (TO PUR COM)
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.